Birks & Mayors Inc. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, filed on March 16, 2010, by Birks & Mayors Inc. (a Canadian corporation), discloses material amendments to executive compensation agreements. The filing does not contain financial results, operational updates, or a specific reporting period for business performance. The primary purpose is to report changes to the employment and equity incentive arrangements for the Chief Executive Officer and Chief Financial Officer.
Key Financial Metrics
The filing text does not provide revenue, profit, cash flow, margins, debt, or liquidity figures. The only financial data present relates to the terms of executive equity grants:
- New CEO Stock Option: 242,944 Class A voting shares at an exercise price of US$1.00 per share.
- CEO Stock Appreciation Rights (SARs): Reduced to 17,390 shares with an exercise price of US$1.00 per share.
- CFO Stock Appreciation Rights (SARs): Reduced to 4,347 shares with an exercise price of US$1.00 per share.
Material Changes
The filing details significant restructuring of equity compensation for key executives effective March 16, 2010:
- CEO Option Cancellation and Replacement: All outstanding stock options granted to CEO Thomas Andruskevich under his April 16, 2008 agreement (including anti-dilutive features) were cancelled. These were replaced with a new option for 242,944 shares at US$1.00.
- SAR Restructuring: Existing Stock Appreciation Rights for both the CEO and CFO (Michael Rabinovitch) were amended. The number of shares subject to these rights was significantly reduced, and the exercise price was reset to US$1.00.
- Term Extension: The amended SARs were granted a new ten-year term (expiring March 16, 2020).
- Going-Private Provisions: New provisions were added ensuring that in the event of a going-private transaction, the new CEO option and amended SARs remain outstanding and become exercisable for a cash payment equal to the appreciation in value.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook for future periods. It does not discuss general business risks or contingencies beyond the specific contractual terms of the executive agreements. The primary "risk" disclosed is the dilution potential of the new equity grants and the cash liability associated with the "going-private" cash-out provisions for the executives.
Investor Verification Checklist
- Verify the total number of shares authorized for issuance under the new CEO option (242,944) and the impact on fully diluted share count.
- Confirm the valuation methodology used to determine the "Fair Market Value" for the cash-out provisions in a going-private scenario.
- Review the specific terms of the "anti-dilutive feature" that was cancelled to understand the previous compensation structure.
- Check subsequent filings for any financial impact of these compensation changes on the company's expense recognition.